Engineering Drugs in Academia From Target Identification to

Phase 1 Clinical Trials (Lessons Learned Along the Way)

Arjun Deb, MD

Professor, Medicine, David Geffen School of Medicine at UCLA;

and Professor, Molecular Cell & Developmental Biology,

UCLA College of Letters & Sciences and

Contact – Cri@mednet.ucla.edu

71-105 CHS